0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Malignant - How Bad Policy and Bad Evidence Harm People with Cancer (Hardcover) Loot Price: R869
Discovery Miles 8 690
You Save: R94 (10%)
Malignant - How Bad Policy and Bad Evidence Harm People with Cancer (Hardcover): Vinayak K. Prasad

Malignant - How Bad Policy and Bad Evidence Harm People with Cancer (Hardcover)

Vinayak K. Prasad

 (sign in to rate)
Was R963 Loot Price R869 Discovery Miles 8 690 | Repayment Terms: R81 pm x 12* You Save R94 (10%)

Bookmark and Share

Expected to ship within 12 - 19 working days

How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective. Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel-but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which * promote novel cancer therapies long before credible data are available to support such treatment; and * exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars. Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration. This is a book about how the actions of human beings-our policies, our standards of evidence, and our drug regulation-incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says, * more cancer clinical trials should measure outcomes that actually matter to people with cancer; * patients on those trials should look more like actual global citizens; * we need drug regulators to raise, not perpetually lower, the bar for approval; and * we need unbiased patient advocates and experts. This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer-and how we can avoid repeating the policy and practice mistakes of the past.

General

Imprint: Johns Hopkins University Press
Country of origin: United States
Release date: April 2020
Authors: Vinayak K. Prasad (Assistant Professor of Medicine)
Dimensions: 229 x 152 x 25mm (L x W x T)
Format: Hardcover
Pages: 304
ISBN-13: 978-1-4214-3763-7
Categories: Books > Law > Laws of other jurisdictions & general law > Social law > Public health & safety law
Books > Health, Home & Family > Family & health > Popular medicine > General
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
Promotions
LSN: 1-4214-3763-5
Barcode: 9781421437637

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Cancer: A Love Story - Memoir Of A…
Lauren Segal Paperback  (1)
R360 Discovery Miles 3 600
Targeted Nanomedicine for Breast Cancer…
Shivani Rai Paliwal, Rishi Paliwal Paperback R4,773 Discovery Miles 47 730
Encyclopedia of Infection and Immunity
Nima Rezaei Hardcover R62,178 Discovery Miles 621 780
Immunotherapy in Resistant Cancer: From…
Jorge Morales Montor, Mariana Segovia Hardcover R3,725 Discovery Miles 37 250
Sphingolipids in Cancer, Volume 140
Charles E. Chalfant, Paul B. Fisher Hardcover R3,977 Discovery Miles 39 770
Lung Cancer, An Issue of…
Roy S. Herbst, Daniel Morgensztern Hardcover R2,256 Discovery Miles 22 560
Adjunctive Rehabilitation Approaches to…
Andrea L. Cheville Hardcover R2,257 Discovery Miles 22 570
Pediatric Brain Tumors Update, An Issue…
Lara Brandao Hardcover R2,274 Discovery Miles 22 740
Neuroendocrine Tumors, An Issue of…
Jennifer Chan, Matthew Kulke Hardcover R1,799 Discovery Miles 17 990
Geriatric Oncology, An Issue of Clinics…
Harvey J. Cohen, Arati V Rao Hardcover R1,796 Discovery Miles 17 960
Pulmonary Metastasectomy, An Issue of…
Mark W Onaitis, Thomas A. D'Amico Hardcover R2,658 Discovery Miles 26 580
Testicular Cancer, An Issue of Urologic…
Daniel W. Lin Hardcover R1,800 Discovery Miles 18 000

See more

Partners